Related Experiment Video
Updated: Jun 12, 2026

Assaying Proteasomal Degradation in a Cell-free System in Plants
Published on: March 26, 2014
BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the
Aurore Keutgens1, Xin Zhang, Kateryna Shostak
1Interdisciplinary Cluster for Applied Genoproteomics, GIGA-Research, Unit of Medical Chemistry, Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, University of Liège, Sart-Tilman, 4000 Liège, Belgium.
Abstract:
The oncogenic protein BCL-3 activates or represses gene transcription through binding with the NF-kappaB proteins p50 and p52 and is degraded through a phospho- and GSK3-dependent pathway. However, the mechanisms underlying its degradation remain poorly understood. Yeast two-hybrid analysis led to the identification of the proteasome subunit PSMB1 as a BCL-3-associated protein. The binding of BCL-3 to PSMB1 is required for its degradation through the proteasome. Indeed, PSMB1-depleted cells are defective in degrading polyubiquitinated BCL-3. The N-terminal part of BCL-3 includes lysines 13 and 26 required for the Lys(48)-linked polyubiquitination of BCL-3. Moreover, the E3 ligase FBW7, known to polyubiquitinate a variety of substrates phosphorylated by GSK3, is dispensable for BCL-3 degradation. Thus, our data defined a unique motif of BCL-3 that is needed for its recruitment to the proteasome and identified PSMB1 as a key protein required for the proteasome-mediated degradation of a nuclear and oncogenic IkappaB protein.
Insights
The proteasome subunit PSMB1 is crucial for degrading the oncogenic BCL-3 protein. This study identifies a unique BCL-3 motif essential for its proteasomal recruitment and degradation.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- BCL-3 is an oncogenic protein regulating gene transcription via NF-kappaB.
- The degradation pathway of BCL-3 is not fully understood, despite its importance.
Purpose of the Study:
- To elucidate the mechanisms of BCL-3 degradation.
- To identify proteins involved in BCL-3 proteasomal degradation.
Main Methods:
- Yeast two-hybrid analysis to identify BCL-3 interacting proteins.
- Depletion of proteasome subunit PSMB1 to assess its role in BCL-3 degradation.
- Analysis of BCL-3 ubiquitination and specific lysine residues.
Main Results:
- PSMB1 was identified as a BCL-3-associated protein essential for its proteasomal degradation.
- PSMB1 depletion impairs the degradation of polyubiquitinated BCL-3.
- Lysines 13 and 26 of BCL-3 are required for its ubiquitination, but the E3 ligase FBW7 is not involved.
Conclusions:
- PSMB1 is a key factor in the proteasome-mediated degradation of BCL-3.
- A unique BCL-3 motif facilitates its recruitment to the proteasome.
- This finding sheds light on the regulation of an oncogenic protein within the nucleus.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

